Organization

Centre Hospitalier Régional Metz-Thionville

3 clinical trials

2 abstracts

Abstract
Circulating tumor DNA analysis in patients with BRAF-mutated metastatic cutaneous melanoma treated with BRAF and MEK inhibitors: Analysis of the OPTIMEL study.
Org: Service de Biopathologie, CNRS UMR 7039 CRAN Université de Lorraine, Methodology Biostatistics Unit pour Nassim, CHRU Nancy, Centre Hospitalier Régional Metz-Thionville,
Abstract
Tebentafusp (tebe) in a real-world cohort of 72 French metastatic uveal melanoma (UM) patients (pts).
Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Institut Curie, Saint Cloud, France, APHP-INSERM U1149 Universite Paris Diderot, Curie Institute, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Clinical trial
INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults
Status: Not yet recruiting, Estimated PCD: 2026-11-05